Skip to main

Medical Subject Headings (thesaurus)

Search from vocabulary

mapear
anotar
descargar

Concept information

... > Chemical Actions and Uses > Toxic Actions > Noxae > Antimetabolites > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Molecular Mechanisms of Pharmacological Action > Antimetabolites > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Therapeutic Uses > Lipid Regulating Agents > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Molecular Mechanisms of Pharmacological Action > Enzyme Inhibitors > Protease Inhibitors > Serine Proteinase Inhibitors > PCSK9 Inhibitors

Término preferido

PCSK9 Inhibitors  

Notice: Undefined index: in /var/www/html/model/Concept.php on line 545

Tipo

  • mesh:Descriptor

Definición

  • Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.

Concepto genérico

En otras lenguas

URI

http://data.loterre.fr/ark:/67375/JVR-F69ZKPPR-N

Descargue este concepto:

RDF/XML TURTLE JSON-LD Creado 9/7/21, última modificación 8/7/21